Navigation Links
Cepheid Reports 2013 Second Quarter Results
Date:7/18/2013

29565,69567,06165,361Shares used in computing diluted net income (loss) per share 

67,29568,86967,06165,361CEPHEIDCONDENSED CONSOLIDATED UNAUDITED BALANCE SHEETS(in thousands)June 30, 2013December
31, 2012
ASSETSCurrent assets: Cash and cash equivalents

$ 85,030$ 95,779 Accounts receivable, net

47,82843,999 Inventory

85,01070,114 Prepaid expenses and other current assets

15,2639,448Total current assets

233,131219,340Property and equipment, net

66,23254,830Other non-current assets

1,078913Intangible assets, net

18,51618,767Goodwill

39,68137,694Total assets

$ 358,638$ 331,544LIABILITIES AND SHAREHOLDERS' EQUITYCurrent liabilities: Accounts payable

$ 40,436$ 33,701 Accrued compensation

19,20416,540 Accrued royalties

7,3307,992 Accrued and other liabilities

4,0404,235 Current portion of deferred revenue

11,3009,599 Current portion of notes payable

183183Total current liabilities

82,49372,250Long-term portion of deferred revenue

8771,156Notes payable, less current portion

1,5411,685Other liabilities

9,7508,911Total liabilities

94,66184,002Shareholders' equity: Common stock

365,317355,867 Additional paid-in capital

130,429117,217 Accumulated other comprehensive income

9656 Accumulated deficit

(231,865)(225,598)Total shareholders' equity

263,977247,542Total liabilities and shareholders' equity

$ 358,638$ 331,544 CEPHEIDCONDENSED CONSOLIDATED UNAUDITED STATEMENTS OF CASH FLOWS(in thousands)Six Months Ended
June 30, 20132012Cash flows from operating activities:Net income (loss)

$
(6,267
'/>"/>

SOURCE Cepheid
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Cepheid Welcomes Senior Vice President of Human Resources
2. Cepheid Reports Fourth Quarter and Full Year 2011 Results
3. Cepheid to Webcast Upcoming Financial Presentations
4. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
5. Diagnostic Marketing Association Names Cepheid 2011 Marketer of the Year
6. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
7. Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
8. Cepheid Reports 2012 Second Quarter Results
9. Cepheid Announces Board of Directors Changes
10. Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings
11. Cepheid Reports 2013 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  RXi Pharmaceuticals ... focused on discovering and developing innovative therapies primarily ... an update on the status of the Company,s ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ... 3,085 and 21 shares of Series A Preferred ...
(Date:5/26/2015)... WORMS, GERMANY – May 26, 2015 ... announces that its manufacturing facility in Worms, Germany ... EXCiPACTâ„¢, an independent organization that certifies manufacturers, suppliers, ... All three Grace facilities that produce its SYLOID® ... have now received GMP certification, following the Curtis ...
(Date:5/26/2015)... 26, 2015   Intrexon Corporation (NYSE: XON ... Gregory Frost , Ph.D., Senior Vice President and Head of ... Healthcare Conference on Wednesday, June 3 rd , at 1:30 ... New York City . About Intrexon Corporation ... the Bioindustrial Revolution with Better DNA ™ to create ...
(Date:5/26/2015)... 26, 2015   PDI , a leader ... that Oakwood Healthcare in Dearborn, Mich. ... entry in Delivering the Difference ... excellence in building collaborative relationships between infection prevention ... facilities.  Oakwood Healthcare,s infection preventionist, ...
Breaking Biology Technology:RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 2RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 3CORRECTION: Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Intrexon to Present at the Jefferies 2015 Global Healthcare Conference 2PDI Announces Winner in Delivering the Difference Contest 2PDI Announces Winner in Delivering the Difference Contest 3
... N.J., April 15 Quest Diagnostics,Incorporated (NYSE: ... of the,previously disclosed federal government investigation related to ... manufacturing subsidiary closed,voluntarily in 2006. Quest Diagnostics cooperated ... , Quest Diagnostics will ...
... announced today that it,has completed the formation of ... existing group of Senior Advisers. NexBio recently ... investigational drug,candidate for influenza. The new CAB will ... medicine, helping the company to conduct advanced,product development ...
... BELGIUM, Wis., April 15 Mach One Corporation ... company, announces Monte B. Tobin, the President and ... One,s shareholders:Dear Fellow Shareholders:The mission of Mach One ... global wellness organizations that provide bio-based solutions to ...
Cached Biology Technology:Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006 2NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 2NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 3NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza 4Mach One CEO Letter to Shareholders 2Mach One CEO Letter to Shareholders 3Mach One CEO Letter to Shareholders 4
(Date:4/20/2015)... The announcement comes as demand for fire ... Ireland,s foremost records management company, has ... an impressive track record of clients within the first 12 ... management sector in Dubai . As a ... employ a further eight staff members at its Irish headquarters. ...
(Date:4/14/2015)... 14, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... 2015 New York Design Awards under the category  ,Product ... City Design Awards are part of a global multi-disciplinary ... ratings from the marketplace, industry and judging panel. Winners ...
(Date:4/10/2015)... April 10, 2015 Research and ... the "Security Competitive Profiles - NEC" report ... NEC will continue to supply a range ... market, with a company focus on the development of ... Winning opportunities in the Asia-Pacific ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3NEC Security Competitive Profile 2015 2
... are those that occur outside their natural range and ... can be plants, animals or microorganisms that are introduced ... tourism, travel or trade, or when domestic animals become ... the rising cost of invasive species on a global ...
... were once credited with magical healing powers but are now ... but the cause of numerous diseases such as diabetes if ... the vital role played by more complex sugars in many ... This all emerged in a recent workshop organised by ...
... (Jan. 16, 2008) -- Two major federal grants have been ... in New York City. Dr. Kenneth W. Griffin ... from the National Institute on Drug Abuse (NIDA) for research ... previously delivered to urban minority youth attending New York City ...
Cached Biology News:Scientists call for urgent research into 'real' impacts of invasive species 2Scientists call for urgent research into 'real' impacts of invasive species 3ESF's workshop restores good name of sugar 2ESF's workshop restores good name of sugar 32 federal public health grants awarded to Weill Cornell Medical College 2